Caprock Group LLC Sells 53 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Caprock Group LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,241 shares of the healthcare conglomerate’s stock after selling 53 shares during the period. Caprock Group LLC’s holdings in UnitedHealth Group were worth $11,251,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Quarry LP lifted its holdings in shares of UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 37 shares during the period. Anchor Investment Management LLC boosted its position in UnitedHealth Group by 9.5% in the second quarter. Anchor Investment Management LLC now owns 22,182 shares of the healthcare conglomerate’s stock worth $11,297,000 after purchasing an additional 1,920 shares during the last quarter. Centaurus Financial Inc. increased its position in shares of UnitedHealth Group by 76.9% during the 2nd quarter. Centaurus Financial Inc. now owns 6,343 shares of the healthcare conglomerate’s stock valued at $3,230,000 after purchasing an additional 2,757 shares during the last quarter. Greater Midwest Financial Group LLC grew its position in UnitedHealth Group by 5.0% during the second quarter. Greater Midwest Financial Group LLC now owns 4,510 shares of the healthcare conglomerate’s stock valued at $2,297,000 after buying an additional 214 shares during the period. Finally, Ashburton Jersey Ltd purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $139,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH opened at $545.06 on Friday. The business has a 50 day simple moving average of $537.14 and a 200-day simple moving average of $564.96. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market capitalization of $501.60 billion, a price-to-earnings ratio of 35.16, a PEG ratio of 1.46 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

UNH has been the topic of several analyst reports. Morgan Stanley cut their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Bank of America reduced their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Finally, Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.